PAVmed Inc.

0.76
-0.01 (-1.04%)
At close: Mar 28, 2025, 3:59 PM
0.72
-4.82%
After-hours: Mar 28, 2025, 05:27 PM EDT
-1.04%
Bid 0.7
Market Cap 12.7M
Revenue (ttm) 5.31M
Net Income (ttm) 70.56M
EPS (ttm) 0.5
PE Ratio (ttm) 1.51
Forward PE -0.42
Analyst Buy
Ask 0.8
Volume 104,568
Avg. Volume (20D) 196,761
Open 0.76
Previous Close 0.77
Day's Range 0.71 - 0.77
52-Week Range 0.57 - 2.43
Beta 1.19

About PAVM

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation...

Sector Healthcare
IPO Date Jul 27, 2016
Employees 39
Stock Exchange NASDAQ
Ticker Symbol PAVM
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for PAVM stock is "Buy." The 12-month stock price forecast is $19, which is an increase of 2410.57% from the latest price.

Stock Forecasts

Next Earnings Release

PAVmed Inc. is scheduled to release its earnings on May 12, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
2 days ago
+7.31%
PAVmed shares are trading higher on possible conti... Unlock content with Pro Subscription
10 months ago
+15.63%
PAVmed shares are trading higher after the company reported better-than-expected Q1 Adj. EPS results.